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a b s t r a c t
Background: Previous research has suggested the clinical proﬁle of individuals with bipolar disorder (BD)
differs according to the presence or absence of comorbid migraine. We aimed to determine the clinical
characteristics that differentiate individuals with BD with and without comorbid migraine in a large,
representative, clinically well-characterised UK sample.
Methods: The lifetime clinical characteristics of 1488 individuals with BD (BPI n¼1120, BPII n¼368) with
and without comorbid migraine were compared (n¼375 vs. n¼1113 respectively).
Results: Individuals with BD and comorbid migraine had a distinctive set of lifetime clinical character-
istics. A multivariate model showed that consistent with previous studies those with comorbid migraine
were signiﬁcantly more likely to be female (OR¼2.099, p¼0.005) and have comorbid panic attacks
(OR¼1.842, p¼0.004). A novel ﬁnding was that even after controlling for other differences, the
individuals with BD and comorbid migraine were more likely to have a rapid cycling illness course
(OR¼1.888, p¼0.002).
Limitations: Presence of migraine was assessed using self report measures. Cross-sectional study design
limits investigations of bidirectional associations between migraine and bipolar disorder.
Conclusions: Comorbid migraine in BD may represent a more homogenous subtype of BD with an
unstable rapid cycling course. Identifying individuals with BD and comorbid migraine may be of use in a
clinical setting and this subgroup could be the focus of future aetiological studies.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Migraine is a common chronic headache disorder, affecting
approximately 12% of the general population (Breslau et al., 1991).
The condition is characterised by recurrent attacks lasting 4–72 h,
typically of a pulsating quality, moderate or severe intensity,
aggravated by routine physical activity and associated with nausea,
vomiting, photophobia or phonophobia (Headache Classiﬁcation
Subcommittee of the International Headache Society, 2004).
Migraine is frequently comorbid with bipolar disorder (BD) (Low
et al., 2003; Mahmood et al., 1999; McIntyre et al., 2006; Ortiz et al.,
2010). Prevalence rates of migraine among individuals with BD have
been reported to be around 25% (Mahmood et al., 1999; McIntyre
et al., 2006; Ortiz et al., 2010). Although past studies have suggested
that the prevalence of migraine is higher in affective disorders than
in the general population with no difference between those with
bipolar and unipolar disorder (Fasmer, 2001); one study found ind-
ividuals with BD to be 2.9 times more likely to have migraine than
those with major depressive disorder (Dilsaver et al., 2009)
suggesting migraine is linked to bipolarity. A recent systematic
review of BD-migraine comorbidity highlighted particularly high
prevalence rates of migraine among women with bipolar II
disorder (Fornaro et al., 2014).
Previous studies have shown that individuals with comorbid BD
and migraine have different clinical characteristics to individuals
with BD without migraine. Earlier age of onset of BD (Mahmood
et al., 1999; McIntyre et al., 2006), increased prevalence of comorbid
panic disorders (Fasmer and Oedegaard, 2001; Ortiz et al., 2010),
higher prevalence of bipolar II disorder subtype (Fasmer and
Oedegaard, 2001; Ortiz et al., 2010) and higher rate of attempted
suicide (Ortiz et al., 2010) have all been associated with BD with
comorbid migraine. These differences support the proposal that the
presence of comorbid migraine represents a more homogenous
subtype of BD. Clinical homogeneity may represent aetiological
homogeneity and this subgroup could be the focus of future
aetiological studies, which could lead to a better understanding of
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the pathogenesis of BD and migraine. Furthermore, this subgroup
could beneﬁt clinically from more effective targeted diagnostic and
management strategies.
Further evidence is needed to conﬁrm and reﬁne BD and com-
orbid migraine as a suggested homogenous phenotypic subgroup.
This study will build on previous smaller scale studies by examin-
ing differences in clinical characteristics between individuals with
BD with and without comorbid migraine, using a large, represen-
tative, well-characterised UK nationwide sample.
2. Materials and methods
The study was part of our ongoing programme of research into
the genetic and non-genetic determinants of BD and related mood
disorders (Bipolar Disorder Research Network, BDRN; bdrn.org)
which has UK National Health Service (NHS) Research Ethics Com-
mittee approval and local Research and Development approval in
all participating NHS Trusts/Health Boards.
2.1. Recruitment of participants
Participants were recruited throughout the UK via systematic
and non-systematic recruitment methods. Systematic recruitment
involved screening for potential participants through Community
Mental Health Teams and lithium clinics. Non-systematic recruit-
ment involved advertisements for volunteers on the research team
websites, in local and national media and through patient support
organisations (such as Bipolar UK).
Our research programme inclusion criteria require participants to
be aged 18 years and over, able to provide written informed consent
and meet DSM-IV criteria for major affective disorder. Individuals
are excluded if they: (i) experienced affective illness only as a result
of alcohol or substance dependence or (ii) experienced affective ill-
ness only secondarily to medical illness or medication.
2.2. Psychiatric assessment
Participants were interviewed using the Schedules for Clinical
Assessment in Neuropsychiatry (SCAN) (Wing et al., 1990), which
provides detailed information about lifetime psychopathology.
Psychiatric and general practice case-notes where available were
also reviewed. Based on these data best-estimate lifetime diag-
noses were made according to DSM-IV criteria and key clinical
variables, such as age at onset and number of mood episodes, were
rated. Level of function during each participant's lifetime worst
episode of each of depression and (hypo)mania was assessed using
the Global Assessment Scale (GAS) (Endicott et al., 1976). The GAS
measures overall functioning of an individual during a speciﬁed
time-frame on a continuum from illness to health with scores
ranging from 1–100 (lowest–highest level of functioning). In cases
where there was doubt, diagnostic and clinical ratings were made
by at least two members of the research team blind to each other's
rating and consensus was reached via discussion where necessary.
Inter-rater reliability was formally assessed using 20 random
cases. Mean kappa statistics were 0.85 for DSM-IV diagnoses and
ranged between 0.81 and 0.99 for other key clinical categorical
variables. Mean intra-class correlation coefﬁcients were between
0.91 and 0.97 for key clinical continuous variables. Team members
involved in the interview, rating and diagnostic procedures were
all research psychologists or psychiatrists.
Participants in the current study (n¼1488) were unrelated and
met DSM-IV diagnostic criteria for bipolar I disorder (BPI) (n¼1120)
or bipolar II disorder (BPII) (n¼368).
2.3. Migraine assessment and deﬁnition
History of migraine was assessed via two different methods
during the course of our research programme.
2.3.1. Self-rated migraine questionnaire
A self-rated questionnaire about lifetime experience of migraine
consisted of 11 items relating to migraine frequency, character, dur-
ation, severity, associated symptoms, and aggravating and relieving
factors. Participant responses were used to make a lifetime diagnosis
of migraine according to criteria adapted from the International
Headache Society diagnostic criteria.
2.3.2. Doctor diagnosis of migraine
During a later wave of recruitment, information about lifetime
history of migraine was assessed by an item on a self-report med-
ical history questionnaire asking if participants had ever received a
diagnosis of migraine headaches by a doctor.
Participants were stratiﬁed into the following two groups:
 Migraine group (n¼375): participants with a lifetime diagnosis
of migraine (n¼118) according to the self-rated migraine que-
stionnaire and participants who reported a doctor diagnosis of
migraine (n¼257).
 No migraine group (n¼1113): participants who did not have a
history of migraine according to the self-rated migraine ques-
tionnaire (n¼211) or self-report medical questionnaire (n¼902).
2.4. Statistical analysis
The data were analysed using SPSS. The majority of data were
not normally distributed so non-parametric statistical tests were
used. Demographic and clinical characteristics of the two groups
were compared using chi-square tests for categorical data and
Mann–Whitney U tests for continuous data. All demographic and
clinical characteristics signiﬁcant at po0.05 in the univariate ana-
lyses were included as explanatory variables in a logistic regres-
sion model using the forward stepwise likelihood ratio method
with absence or presence of migraine as the outcome/dependent
variable.
3. Results
There was a signiﬁcantly greater proportion of females in the
migraine compared to no migraine group (80% vs. 67%, po0.001).
Individuals in the migraine group were signiﬁcantly younger at
interview (44 vs. 47 years, p¼0.001). There were no other sign-
iﬁcant demographic differences between the migraine and no
migraine groups (Table 1).
The clinical characteristics of BD in the migraine and no mig-
raine groups are summarised in Table 2. Compared to participants
without a history of migraines, individuals in the migraine group
had signiﬁcantly:
 Higher rate of history of panic attacks (63% vs. 44%, po0.001)
 Higher rate of rapid cycling, deﬁned as 4 or more episodes in
any 12 month period (39% vs. 30%, p¼0.011)
 Higher rate of family history of affective disorders (89% vs.83%,
p¼0.020)
 Lower rate of history of psychiatric admission (70% vs. 78%,
p¼0.002)
 Younger age at illness onset, deﬁned as the age at which sym-
ptoms of affective disorder ﬁrst caused signiﬁcant impairment
(19 vs. 21 years, po0.001)
K. Gordon-Smith et al. / Journal of Affective Disorders 175 (2015) 320–324 321
 Less impairment in functioning during worst episode of (hypo)
mania, indicated by higher GAS scores (35 vs. 31, p¼0.002)
Sex, age at interview and all clinical variables listed above were
entered into a logistic regression analysis, which indicated the
characteristics that best predicted the presence of comorbid
migraine were being female (OR 2.099, 95% CI: 1.254–3.515,
p¼0.005), history of panic attacks (OR 1.842, 95% CI: 1.221–2.779
p¼0.004) and a rapid cycling illness course (OR 1.888, 95% CI:
1.251–2.848, p¼0.002).This model accounted 7.9% of the variance
and correctly classiﬁed 79.2% of participants as having comorbid
migraine or not.
4. Discussion
Our ﬁndings are in agreement with previous studies that have
found differences in clinical characteristics between BD with and
without comorbid migraine. The strength of our study is the large,
robust, representative and clinically well-characterised sample.
The prevalence of migraine in our sample was 25% which is
accordant with previous studies (Mahmood et al., 1999; McIntyre
et al., 2006; Ortiz et al., 2010).
When other signiﬁcant differences were controlled for, indivi-
duals with comorbid migraine were more likely to be female, have
comorbid panic attacks and a rapid cycling illness. Our ﬁnding of an
independent association between rapid cycling BD and migraine,
which remained signiﬁcant in multivariate analysis, is novel. This has
only been investigated in two other recent studies which also found
a higher prevalence of rapid cycling among individuals with BD and
comorbid migraine although this was not observed after correction
for multiple comparisons (Brietzke et al., 2012b) or in multivariate
analysis (Saunders et al., 2014). Brietzke et al (2012b) had a lower
percentage of BPII cases than our BD sample (10% vs. 25% resp-
ectively); however, as in our sample BPII disorder was not associated
with migraine in their report. In the study by Saunders et al. (2014)
Table 1
Demographic characteristics according to diagnosis of migraine.
Migraine (n¼375) No migraine (n¼1113) P value
Sex, n (%)
Female 300 (80.0) 743 (66.8) o0.001
Age at interview (years)
Median 44 47 0.001
Iq R 16 20
Range 19–73 18–80
Highest educational level, n (%)
CSE/O-level/GCSE 85 (23.5) 236 (22) 0.480
A-level/HND/BTEC 107 (29.6) 276 (25.7)
Degree 95 (26.3) 316 (29.4)
Postgraduate degree 46 (12.7) 154 (14.3)
Highest occupation level, n (%)
Legislators, senior ofﬁcials, managers and professionals 123 (34.5) 407 (37.6) 0.063
Technicians, associate professionals and civil servants 63 (17.6) 202 (18.7)
All other occupations 168 (47.1) 442 (40.9)
Never worked 0 (0) 13 (1.2)
Student 3 (0.8) 18 (1.7)
Recruitment, n (%)
Systematic 81 (22.2) 221 (20.1) 0.403
Iq R¼ interquartile range. Figures in bold indicate variables (po0.05) to be entered into regression model. Totals vary due to unknown/missing data.
Table 2






DSMIV diagnosis, n (%)
BPI 280 (74.7) 840 (75.5) 0.755
BPII 95 (25.3) 273 (24.5)
History of panic attacks, n (%) 154 (63.4) 392 (44.3) o0.001
History of rapid cycling, n (%) 94 (38.8) 235 (30.1) 0.011
History of suicide attempt, n (%) 198 (54.1) 527 (49.3) 0.109
Family history of affective
disorder n (%)
284 (88.8) 790 (83.3) 0.020
History of psychotic symptoms,
n (%)
215 (66.8) 641 (66.8) 1.000
History of psychiatric
admission, n (%)
257 (70.4) 848 (78.3) 0.002
Age at illness onset
Median 19 21 o0.001
Iq R 10 12
Range 4–63 4–64
No. episodes depression
Median 8 8 0.232
Iq R 16 16
Range 0–250 0–100
No. episodes (hypo)mania
Median 6 6 0.509
Iq R 8 8
Range 1–250 1–100
GAS score during worst
depression
Median 40 40 0.489
Iq R 14 13
Range 10–61 10–71
GAS score during worst (hypo)
mania
Median 35 31 0.002
Iq R 30 28
Range 10–61 8–68
Iq R¼ inter-quartile range; GAS¼Global Assessment Scale; BPI¼bipolar I disorder;
BPII¼bipolar II disorder. Figures in bold indicate variables (po0.05) to be entered
into regression model. Totals vary due to unknown/missing data.
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lifetime serotonin noradrenaline reuptake inhibitor use was included
in the multivariate model which was not included in the present
study. The higher percentage of women in the migraine group is
compatible with the higher rate of migraine among women than
men in the general population (Breslau et al., 1991; Jette et al., 2008)
and in previous studies in BD (Baptista et al., 2012; Saunders et al.,
2014). In line with previous studies, comorbid migraine was asso-
ciated with a higher prevalence of lifetime history of panic attacks
(Fasmer and Oedegaard, 2001; Ortiz et al., 2010). Numerous studies
have found a relationship between BD and panic disorder (Freeman
et al., 2002) and we have previously found that the presence of panic
attacks may differentiate between subgroups of individuals with BD
(Forty et al., 2009). The ﬁndings of our current study suggest that the
relationship between BD and panic attacks may be stronger among
those with comorbid migraine. Individuals in the migraine group also
had a signiﬁcantly younger age of onset of BD.
In contrast to some previous studies that have found an associa-
tion between migraine and BPII disorder (Fasmer and Oedegaard,
2001; Ortiz et al., 2010), we did not ﬁnd a higher prevalence of BPII
disorder in the migraine group. However, individuals in the migraine
group had signiﬁcantly higher GAS scores during their worst episode
of high mood indicating less impairment in functioning in the uni-
variate analyses. Because of previously reported associations bet-
ween migraine and BPII disorder we repeated our analysis in the
BPI and BPII groups separately and the outcomes were the same.
Our ﬁndings in the whole BD sample were not accounted for by the
BPII cases.
Our ﬁndings provide further evidence that comorbid migraine in
BD represents a more homogenous subgroup of BD that may be
associated with an unstable rapid cycling illness course. The identi-
ﬁcation of a distinct subgroup of individuals with BD has signiﬁcant
implications for future research and clinical practice. There is evidence
that there are common neurobiological pathways underlying BD and
migraine, for example, a number of pharmacological treatments incl-
uding valproate are used to treat both conditions (Peterson and
Naunton, 2005). Inﬂammatory cytokines have also been implicated in
the neurobiology of both BD and migraine (Brietzke et al., 2012a). The
aetiologies of both conditions are currently unknown although both
disorders are recognised to have multifactorial polygenic aetiology
and research suggests they may share common pathophysiology. A
genome-wide association study of BD found evidence of association
for several single-nucleotide polymorphisms on chromosome 13q14.1
with a small sample of patients with doctor-diagnosed comorbid
migraine (n¼56) (Oedegaard et al., 2010a). The role of ion channne-
lopathies has been proposed in the pathogenesis of both disorders
and in particular calcium channelopathy. Genome-wide association
studies have found evidence for an association between CACNA1C
(alpha 1C subunit of the L-type voltage-gated calcium channel) gene
variants and BD (Ferreira et al., 2008; Sklar et al., 2011) and mutations
in a calcium channel encoding gene CACNA1A (alpha 1A subunit of
P/Q type voltage-dependent calcium channel) have been found to
cause familial hemiplegic migraine type 1 (Gargus, 2009). A genome-
wide linkage study of BD and comorbid migraine identiﬁed an over-
lapping susceptibility locus for both disorders on chromosome 20p11,
a region containing a gene involved in calcium homoeostasis, sugg-
esting that some genes may predispose individuals to both BD and
migraine (Oedegaard et al., 2010b). However, another study did not
ﬁnd any evidence of an association between a genetic variant in
CACNA1C that has been associated with BD and migraine in a sample
of 192 families with a proband with childhood migraine (Wober-
Bingol et al., 2011).
A potential limitation of this study is that the presence/absence of
migraine was determined by self-report. It is however reassuring that
when the accuracy of the self-report medical history questionnaire
was previously assessed, agreement between general practitioners
and participants for the presence or absence of a medical disorder
was 93% (Farmer et al., 2008). In order to increase our sample size, we
combined data collected on migraine headaches during different
waves of recruitment to our research programme. Analysis of the
level of agreement between the two measures in a different sample
found a moderate level of agreement (k¼0.55) with the single
migraine item from the medical history questionnaire being the more
conservative of the two. We also carried out separate analyses on the
participants who completed the migraine questionnaire (n¼359) and
the medical history questionnaire (n¼1237) and the direction of
association was the same in all cases, although the effect sizes were
slightly smaller in the migraine questionnaire group. The amount of
variance explained by the logistic regression was small (8%), although
this was not unexpected given the multifactorial aetiology of mig-
raine. For the majority of cases the presence of migraine was asses-
sed by the single item on a medical questionnaire meaning we were
unable to separate the migraine group further into those with and
without aura. Further in depth analyses of comorbid migraine in BD
are required in large samples with more detailed information about
the migraine phenotype such as the presence of aura.
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